Search This Blog

Monday, April 1, 2019

Ziopharm initiated with a Buy at Laidlaw

Laidlaw analyst Yale Jen initiated Ziopharm with a Buy and $7.50 price target.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.